0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Parkinson Disease/Parkinsonian Disorders
 1-20 of 76 Articles
Viewpoint | 
Anat Mirelman, PhD; Nir Giladi, MD; Jeffrey M. Hausdorff, PhD
JAMA. 2015;314(9):873-874. doi:10.1001/jama.2015.8530.

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2015;314(5):443. doi:10.1001/jama.2015.9102.

Original Investigation |  FREE
Writing Group for the NINDS Exploratory Trials in Parkinson Disease (NET-PD) Investigators
JAMA. 2015;313(6):584-593. doi:10.1001/jama.2015.120.
Includes: Supplemental Content

Health Agencies Update | 
Tracy Hampton, PhD
JAMA. 2014;312(20):2082. doi:10.1001/jama.2014.15133.

Viewpoint |  FREE
Mahlon R. DeLong, MD; Alim-Louis Benabid, MD, PhD
JAMA. 2014;312(11):1093-1094. doi:10.1001/jama.2014.11132.

JAMA Revisited | 
Edward Livingston Hunt, M.D.; Leon H. Cornwall, M.D.
JAMA. 2014;311(16):1696. doi:10.1001/jama.2013.279467.

From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2014;311(16):1686-1687. doi:10.1001/jama.2014.3323.

Review | 
Barbara S. Connolly, MD; Anthony E. Lang, MD
JAMA. 2014;311(16):1670-1683. doi:10.1001/jama.2014.3654.
Includes: CME, Supplemental Content

Grand Rounds | 
W. Jeffrey Elias, MD; Binit B. Shah, MD
JAMA. 2014;311(9):948-954. doi:10.1001/jama.2014.1397.

From the JAMA Network | 
Danny Bega, MD; Dimitri Krainc, MD, PhD
JAMA. 2014;311(6):617-618. doi:10.1001/jama.2013.285516.

news@JAMA | 
JAMA. 2014;311(5):455. doi:10.1001/jama.2014.24.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2013;309(8):759. doi:10.1001/jama.2013.1276.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2013;309(5):431. doi:10.1001/jama.2013.267.

Clinical Crossroads | 
Daniel Tarsy, MD
JAMA. 2012;307(21):2305-2314. doi:10.1001/jama.2012.4829.
Includes: CME, Supplemental Content

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2012;307(9):904. doi:10.1001/jama.2012.224.

Medical News and Perspectives | 
Bridget M. Kuehn
JAMA. 2011;306(8):814. doi:10.1001/jama.2011.1205.

Health Agencies Update | 
Bridget M. Kuehn
JAMA. 2011;305(12):1188. doi:10.1001/jama.2011.318.

Clinical Crossroads | 
Matthew Rizzo, MD
JAMA. 2011;305(10):1018-1026. doi:10.1001/jama.2011.252.
Includes: CME

Medical News and Perspectives | 
Mike Mitka
JAMA. 2010;304(12):1315-1316. doi:10.1001/jama.2010.1329.

Health Agencies Update | 
Bridget M. Kuehn
JAMA. 2010;303(24):2464. doi:10.1001/jama.2010.837.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Neurology
Obituary  | 
In Memoriam: Oliver Sacks, MD (July 9, 1933, to August 30, 2015)
Lewis P. Rowland, MD
JAMA Neurology
Editorial  | 
New and Appropriate Goals for Parkinson Disease Physical Therapy
J. Eric Ahlskog, PhD, MD
JAMA Neurology
Original Investigation  | 
Physiotherapy and Occupational Therapy vs No Therapy in Mild to Moderate Parkinson Disease A Randomized Clinical Trial
Carl E. Clarke, MD; Smitaa Patel, MSc; Natalie Ives, MSc; et al.
JAMA Neurology
Original Investigation  | 
Association Between Change in Body Mass Index, Unified Parkinson’s Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1
Anne-Marie A. Wills, MD, MPH; Adriana Pérez, PhD; Jue Wang, MS; et al.